StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a report issued on Sunday. The brokerage issued a hold rating on the stock.
TherapeuticsMD Price Performance
TherapeuticsMD stock opened at $1.62 on Friday. The business’s fifty day simple moving average is $1.79 and its two-hundred day simple moving average is $2.05. TherapeuticsMD has a 12 month low of $1.43 and a 12 month high of $4.03.
TherapeuticsMD (NASDAQ:TXMD – Get Free Report) last announced its quarterly earnings results on Monday, August 12th. The company reported ($0.09) earnings per share (EPS) for the quarter. The firm had revenue of $0.23 million during the quarter.
Institutional Inflows and Outflows
TherapeuticsMD Company Profile
TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.
See Also
- Five stocks we like better than TherapeuticsMD
- What is the S&P/TSX Index?
- Brinker International’s Price Dip is an Appetizing Entry Point
- 3 Best Fintech Stocks for a Portfolio Boost
- 3 Stocks That Could Beat the September Blues
- Stock Splits, Do They Really Impact Investors?
- Canopy Growth Stock: Can It Sustain Recent Gains?
Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.